ASTX Share Price

Open 8.51 Change Price %
High 8.51 1 Day 0.00 0.00
Low 8.48 1 Week 0.00 0.00
Close 8.49 1 Month 0.00 0.00
Volume 1718653 1 Year 0.00 0.00
52 Week High 0.20
52 Week Low 0.01
ASTX Important Levels
Resistance 2 8.52
Resistance 1 8.51
Pivot 8.49
Support 1 8.47
Support 2 8.46
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.45 7.29%
MU 20.45 7.29%
MU 20.45 7.29%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ANTH 2.03 38.10%
EMKR 8.45 31.01%
MBLX 0.32 28.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
HTCO 8.00 23.08%
ATEA 1.95 21.88%
ATEA 1.95 21.88%
More..
NASDAQ USA Top Losers Stocks
DSTI 0.00 -100.00%
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX)

ASTX Technical Analysis 5
As on 10th Oct 2013 ASTX Share Price closed @ 8.49 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.78 & Strong Buy for SHORT-TERM with Stoploss of 7.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
ASTX Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
ASTX Other Details
Segment EQ
Market Capital 221088928.00
Sector Consumer Durables Major Pharmaceuticals
Industry
Offical website
ASTX Address
ASTX
N/A
ASTX Latest News
Astex Pharmaceuticals Enters Clinical Trial Collaboration to Explore the ...   Business Wire (press release)   - 20th Apr 16
Astex Pharmaceuticals Announces Orphan Drug Designation for Guadecitabine (SGI ...   Business Wire (press release)   - 06th Oct 15
Astex Pharmaceuticals Announces Publication of Key Clinical Data for ...   Business Wire (press release)   - 19th Aug 15
Pomerantz Announces Notice of Dismissal of Astex Pharmaceuticals, Inc. Class ...   GlobeNewswire (press release)   - 11th Nov 14
Astex Pharmaceuticals Presents Final Results of Phase 2 Study of SGI-110 in ...   Business Wire (press release)   - 16th Jun 14
Astex Pharma shareholder opposes $886 million bid by Otsuka   Reuters   - 03rd Oct 13
Japan's Otsuka to buy US cancer firm Astex for $886 million   Reuters   - 05th Sep 13
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in ...   GlobeNewswire (press release)   - 08th Jul 13
James Manuso, chairman and CEO of Astex Pharmaceuticals Inc.   San Francisco Business Times   - 20th Jul 12
SuperGen, Inc. Changes Name To Astex Pharmaceuticals, Inc., Announces New ...   TheStreet.com (press release)   - 12th Sep 11
Interactive Technical Analysis Chart Astex Pharmaceuticals, Inc. ( ASTX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Astex Pharmaceuticals, Inc.
ASTX Business Profile
Astex Pharmaceuticals, Inc.